LEADER 01743nam  2200457Ia 450 
001 9910696947903321
005 20230902161804.0
035   $a(CKB)5470000002383413
035   $a(OCoLC)551147585
035   $a(EXLCZ)995470000002383413
100   $a20100311d2009      ua             0
101 0 $aeng
135   $auran|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aGuidance for industry$b[electronic resource] $epresenting risk information in prescription drug and medical device promotion
210  1$aRockville, MD :$cU.S. Dept. of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research,$d[2009]
215   $a1 electronic resource (24 pages)
300   $a"Center for Biologics Evaluation and Research (CBER)."
300   $a"Center for Veterinary Medicine (CVM)."
300   $a"Center for Devices and Radiological Health (CDRH)."
300   $a"Draft guidance."
300   $a"May 2009."
517   $aGuidance for industry 
606   $aDrugs$xSide effects$zUnited States
606   $aAdvertising$xDrugs$zUnited States
606   $aAdvertising$xMedical instruments and apparatus
615  0$aDrugs$xSide effects
615  0$aAdvertising$xDrugs
615  0$aAdvertising$xMedical instruments and apparatus.
712 02$aCenter for Drug Evaluation and Research (U.S.)
712 02$aCenter for Biologics Evaluation and Research (U.S.)
712 02$aCenter for Veterinary Medicine (U.S.)
712 02$aCenter for Devices and Radiological Health (U.S.)
801  0$bGPO
801  1$bGPO
906   $aBOOK
912   $a9910696947903321
996   $aGuidance for industry$93434577
997   $aUNINA